Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Trillions.
The item "End-Period-Cash-Flow" stands at 0.99 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 03/31/2021.
Kyowa Kirin Co Ltd's second quarter result of 0.2346 Trillion JPY for the item "End Period Cash Flow" represents an increase of 9.44 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 0.2346 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -24.60 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 0.99 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -7.18 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -30.75 percent compared to the value the year prior.
The 1 year change in percent is -30.75.
The 3 year change in percent is -25.67.
The 5 year change in percent is 157.61.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - End Period Cash Flow | 905,699,262,464.00 |
![]() | Johnson & Johnson - End Period Cash Flow | 486,508,953,600.00 |
![]() | AbbVie Inc - End Period Cash Flow | 399,570,305,024.00 |
![]() | Roche Holding AG - End Period Cash Flow | 317,433,206,677.55 |
![]() | AstraZeneca PLC - End Period Cash Flow | 280,205,508,085.11 |